Robert Goldman

Company: MapLight Therapeutics

Job title: Senior Vice President, Head, Medical Affairs

Seminars:

Panel Discussion: Reframing Muscarinic Modulation: Lessons from Trials, Selectivity Challenges & the Placebo Puzzle 10:00 am

Explore real-world clinical trial insights, including implications of placebo response and operational variability on muscarinic agent outcomes. Discuss the evolving understanding of M1 vs. M4 receptor agonism and their roles in achieving therapeutic efficacy in schizophrenia.Read more

day: Day One